Overexpression of interferon α/β receptor β chain in fetal down syndrome brain

Neuroembryology

Volumn 2, Issue 4, 2003, Pages 147-155

  Ferrando Miguel, Rosa ^a   Shim, Ki Shuk ^a   Cheon, Myeong Sook ^a   Gimona, Mario ^b   Furuse, Mikio ^c   Lubec, Gert ^a,d  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^c KYOTO UNIVERSITY   (Japan)

^d UNIVERSITY OF VIENNA   (Austria)

Author keywords

Claudin 8; Fetal brain; Glutamate receptor 5; H2 calponin; Immunoblotting; Oligodendrocyte transcription factor 1; Protein expression

Indexed keywords

ABC TRANSPORTER; BETA ACTIN; BETA2 INTEGRIN; CALPONIN; CLAUDIN; DISINTEGRIN; DNA METHYLTRANSFERASE; GLUTAMATE RECEPTOR 5; INTERFERON ALPHA RECEPTOR BETA CHAIN; INTERFERON BETA RECEPTOR BETA CHAIN; INTERFERON RECEPTOR; METALLOPROTEINASE; OLIGODENDROCYTE TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BETA CHAIN; CHROMOSOME 21; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; FETUS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SECOND TRIMESTER PREGNANCY; STATISTICAL SIGNIFICANCE;

EID: 4644252267     PISSN: 14248522     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079401     Document Type: Article

References (50)

1. Epstein CJ: Down syndrome; in Scriver CR, Beaudet AL, Sly WS, Valle D (eds): The Metabolic and Molecular Bases of Inherited Disease, ed 7. New York, McGraw Hill, 1995, vol I, pp 749-794.
2. Capone GT: Down syndrome: Advances in molecular biology and the neurosciences. J Dev Behav Pediatr 2001;22:40-59.
3. Mao R, Zielke CL, Zielke HR, Pevsner J: Global up-regulation of chromosome 21 gene expression in the developing Down syndrome brain. Genomics 2003;81:457-467.
4. Antonarakis SE: Chromosome 21: From sequence to applications. Curr Opin Genet Dev 2001;11:241-246.
5. Engidawork E, Lubec G: Molecular changes in fetal Down syndrome brain. J Neurochem 2003;84:895-904.
6. Cheon MS, Kim SH, Yaspo ML, Blasi F, Aoki Y, Melen K, Lubec G: Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: Challenging the gene dosage effect hypothesis (Part I). Amino Acids 2003;24:111-117.
7. Cheon MS, Bajo M, Kim SH, Claudio JO, Stewart AK, Patterson D, Kruger WD, Kondoh H, Lubec G: Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: Challenging the gene dosage effect hypothesis (Part II). Amino Acids 2003;24:119-125.
8. Cheon MS, Kim SH, Ovod V, Kopitar Jerala N, Morgan JI, Hatefi Y, Ijuin T, Takenawa T, Lubec G: Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: Challenging the gene dosage effect hypothesis (Part III). Amino Acids 2003;24:127-134.
9. Engidawork E, Lubec G: Protein expression in Down syndrome brain. Amino Acids 2001;21:331-361.
10. Chill JH, Quadt SR, Levy R, Schreiber G, Anglister J: The human type I interferon receptor: NMR structure reveals the molecular basis of ligand binding. Structure (Camb) 2003;11:791-802.
11. Platanias LC, Fish EN: Signaling pathways activated by interferons. Exp Hematol 1999;27:1583-1592.
12. Maroun LE: Interferon action and chromosome 21 trisomy (Down syndrome): 15 years later. J Theor Biol 1996;181:41-46.
13. Su AI, Cooke MP, Ching KA, Hakak Y, Walker JR, Wiltshire T, Orth AP, Vega RG, Sapinoso LM, Morqrich A, Patapoutian A, Hampton GM, Schultz PG, Hogenesch JB: Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci USA 2002;99:4465-4470.
14. Sailer A, Swanson GT, Perez-Otaño I, O'Leary L, Malkmus SA, Dyck RH, Dickinson-Anson H, Schiffer HH, Maron C, Yaksh TL, Gage FH, O'Gorman S, Heinemann SF: Generation and analysis of GluR5 (Q636R) kainate receptor mutant mice. J Neurosci 1999;19:8757-8764.
15. Better B, Boulter J, Hermans-Borgmeyer I, O'Shea-Greenfield A, Deneris ES, Moll C, Borgmeyer U, Hollmann M, Heinemann S: Cloning of a novel glutamate receptor subunit, GluR5: Expression in the nervous system during development. Neuron 1990;5:583-595.
16. Bernard A, Khrestchatisky M: Assessing the extent of RNA editing in the TMII regions of GluR5 and GluR6 kainate receptors during rat brain development. J Neurochem 1994;62:2057-2060.
17. Ritter LM, Unis AS, Meador-Woodruff JH: Ontogeny of ionotropic glutamate receptor expression in human fetal brain. Brain Res Dev Brain Res 2001;127:123-133.
18. Hossain MM, Hwang DY, Huang Q, Sasaki Y, Jin J: Developmentally regulated expression of calponin isoforms and the effect of h2-calponin on cell proliferation. Am J Physiol Cell Physiol 2003;284:156-167.
19. Masuda H, Tanaka K, Takagi M, Ohgami K, Sakamaki T, Shibata N, Takahashi K: Molecular cloning and characterization of human nonsmooth muscle calponin. J Biochem 1996;120:415-424.
20. Wolburg H, Lippoldt A: Tight junctions of the blood-brain barrier: Development, composition and regulation. Vascul Pharmacol 2002;38:323-337.
21. Lamas M, González-Mariscal L, Gutiérrez R: Presence of claudins mRNA in the brain. Selective modulation of expression by kindling epilepsy. Brain Res Mol Brain Res 2002;104:250-254.
22. Zhou Q, Wang S, Anderson DJ: Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors. Neuron 2000;25:331-343.
23. Lu QR, Sun T, Zhu Z, Ma N, Garcia M, Stiles CD, Rowitch DH: Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. Cell 2002;109:75-86.
24. Takebayashi H, Yoshida S, Sugimori M, Kosako H, Kominami R, Nakafuku M, Nabeshima Y: Dynamic expression of basic helix-loop-helix Olig family members: Implication of Olig2 in neuron and oligodendrocyte differentiation and identification of a new member, Olig3. Mech Dev 2000;99:143-148.
25. Rakic S, Zecevic N: Early oligodendrocyte progenitor cells in the human fetal telencephalon. Glia 2003;41:117-127.
26. Chédin F, Lieber MR, Hsieh C: The DNA methyltransferase-like protein DNMT3L stimulates de novo methylation by Dnmt3a. Proc Natl Acad Sci USA 2002;26:16916-16921.
27. Deplus R, Brenner C, Burgers WA, Putmans P, Kouzarides T, de Launoit Y, Fuks F: Dnmt3l is a transcriptional repressor that recruits histone deacetylase. Nucleic Acids Res 2002;30:3831-3838.
28. Aapola U, Shibuya K, Scott HS, Ollila J, Vihinen M, Heino M, Shintani A, Kawasaki K, Minoshima S, Krohn K, Antonarakis SE, Shimizu N, Kudoh J, Peterson P: Isolation and initial characterization of a novel zinc finger gene DNMT3L on 21q22.3, related to the cytosine-5-methyltransferase 3 gene family. Genomics 2000;65:293-298.
29. Lorkowski S, Rust S, Engel T, Jung E, Tegelkamp K, Galinski EA, Assmann G, Cullen P: Genomic sequence and structure of the human ABCG1 (ABC8) gene. Biochem Biophys Res Commun 2001;280:121-131.
30. Klucken J, Büchler Ch, Orsó E, Kaminski WE, Porsch-Özcürümez M, Liebisch G, Kapinsky M, Diederich W, Drobnik W, Dean M, Allikmets R, Schmitz G: ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport. Proc Natl Acad Sci USA 2000;97:817-822.
31. Wei P, Zhao Y, Zhuang L, Hurst R, Ruben S, Sang QX: Protein engineering and properties of human metalloproteinase and thrombospondin 1. Biochem Biophys Res Commun 2002; 293:478-488.
32. Rodríguez-Manzaneque JC, Milchanowski AB, Dufour EK, Leduc R, Iruela-Arispe ML: Characterization of METH-1/ADAMTS1 processing reveals two distinct active forms. J Biol Chem 2000;275:33471-33479.
33. Thai SN, Iruela-Arispe ML: Expression of ADAMTS1 during murine development. Mech Dev 2002;115:181-185.
34. Milner R, Campbell IL: The extracellular matrix and cytokines regulate microglial integrin expression and activation. J Immunol 2003; 170:3850-3858.
35. Akiyama H, McGeer PL: Brain microglia constitutively express beta-2 integrins. J Neuroimmunol 1990;30:81-93.
36. Morita K, Furuse M, Fujimoto K, Tsukita S: Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc Natl Acad Sci USA 1999;96:511-516.
37. Draeger A, Gimona M, Stuckert A, Celis JE, Small JV: Calponin. Developmental isoforms and a low molecular weight variant. FEBS Lett 1991;291:24-28.
38. Ling LE, Zafari M, Reardon D, Brickelmeier M, Goelz SE, Benjamin CD: Human type I interferon receptor, IFNAR, is a heavily glycosylated 120-130 kD membrane protein. J Interferon Cytokine Res 1995;15:55-61.
39. Piehler J, Schreiber G: Biophysical analysis of the interaction of human Ifnar2 expressed in E. coli with IFNα2. J Mol Biol 1999;289:57-67.
40. Plioplys AV, Massimini N: Alpha/beta interferon is a neuronal growth factor. Neuroimmunomodulation 1995;2:31-35.
41. Mendoza-Fernandez V, Andrew RD, Barajas-Lopez C: Interferon-alpha inhibits long-term potentiation and unmasks a long-term depression in the rat hippocampus. Brain Res 2000; 885:14-24.
42. Plioplys AV: Down's syndrome. Precocious neurofilament antigen expression. J Neurol Sci 1987;79:91-100.
43. Plioplys AV: Expression of the 210 kDa neurofilament subunit in cultured central nervous system from normal and trisomy 16 mice: Regulation by interferon. J Neurol Sci 1988;82:209-222.
44. Maroun LE: Anti-interferon immunoglobulins can improve the trisomy 16 mouse phenotype. Teratology 1995;51:329-335.
45. Maroun LE, Heffernan TN, Hallam DM: Partial IFN-α/β and IFN-γ receptor knockout trisomy 16 mouse fetuses show improved growth and cultured neuron viability. J Interferon Cytokine Res 2000;20:197-203.
46. Cutrone EC, Langer JA: Contributions of cloned type I interferon receptor subunits to differential ligand binding. FEBS Lett 1997; 404:197-202.
47. Kuromitsu J, Yamashita H, Kataoka H, Takahara T, Muramatsu M, Sekine T, Okamoto N, Furuichi Y, Hayashizaki Y: A unique downregulation of h2-calponin gene expression in Down syndrome: A possible attenuation mechanism for fetal survival by methylation at the CpG island in the trisomic chromosome 21. Mol Cell Biol 1997;17:707-712.
48. Sasaki M, Seo-Kiryu S, Kato R, Kita S, Kiyama H: A disintegrin and metalloprotease with thrombospondin type 1 motifs (ADAMTS-1) and IL-1 receptor type 1 mRNAs are simultaneously induced in nerve injured motor neurons. Brain Res Mol Brain Res 2001;89:158-163.
49. Asano A, Jin HK, Watanabe T: Mouse Mx2 gene: Organization, mRNA expression and the role of the interferon-response promoter in its regulation. Gene 2003;306:105-113.
50. Grandvaux N, Servant MJ, tenOever B, Sen GC, Balachandran S, Barber GN, Lin R, Hiscott J: Transcriptional profiling of interferon regulatory factor 3 target genes: Direct involvement in the regulation of interferon-stimulated genes. J Virol 2002;76:5532-5539.